Most of these studies have attributed the tumor inhibitory effect of CR to the deceased circulating levels of insulin and IGF-1 and inhibition in its subsequent downstream signaling of PI3K/Akt-mTOR. The gene discussed is AKT1; the disease is neoplasm.